MARKETS / BALCAO / HLYK
BALCAO · SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE · SMALL CAP

HealthLynked Corp. HLYK

10 fiscal years on record · USD · FY2025 reported
SEC FILINGS ONLY
Revenue · FY2025
$2.1M
▼ 31.3% vs FY2024
EPS · FY25
$-1.16
Dividend / sh · FY25
Payout · FY25
ROE · FY25
Net margin · FY25
-158.8%
Dividend coverage
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 2.1M
Revenue, FY2025 · full 10-year series below
Revenue Net income
0.0020.0040.0060.0-0.02016201920222025
0.0020.0040.0060.0-0.02016201920222025

The company lost 159 cents on every revenue dollar this year.

Per share
USD -1.16
Diluted EPS, FY2025
EPS
0.40.81.2-1.162016201920222025
0.40.81.2-1.162016201920222025

The company pays no cash dividend.

Profitability
Return on equity, FY2025
ROE
0.250.50.7512016201920222025
0.250.50.7512016201920222025
Operating margin-102.3%
Net margin-158.8%
Return on assets-167.1%

Returned to shareholders
returned in FY2025 · dividends + net buybacks
Dividends paid
Net buybacks
Share of profit
Consecutive raises

Growth
−15.3% a year
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
−29.4%
−15.3%

Compound annual rates per period — left blank where the series crosses a loss.

Share base
0.00B
Shares outstanding, FY2025
0.070.002016201920222025
0.070.002016201920222025
Change, 5 years
Change, 10 years

A share split breaks the comparison across the period, so we leave it out.

Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 1.7M
total assets, end of FY2025
Total assetsUSD 1.7M
EquityUSD -5.8M
CashUSD 37,136.00
Current ratio0.22×

Equity funds -338% of total assets.

History
10 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
Revenue $B
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
·
Operating income $B
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
EBITDA $B
−0.0
−0.0
−0.0
−0.0
−0.0
·
·
·
·
·
Income tax $B
·
·
·
·
·
·
·
·
·
·
Net income $B
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
EPS, diluted $
−1.16
−2.18
0.00
−0.04
−0.05
−0.04
−0.06
−0.07
−0.04
−0.02
Dividend / sh $
·
·
·
·
·
·
·
·
·
·
Payout %
·
·
·
·
·
·
·
·
·
·
ROE %
·
·
−180.9
−234.5
−243.5
·
·
·
·
·
Shares out B
0.00
0.00
0.28
0.26
0.24
0.19
0.11
0.09
0.07
0.07

Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.

How we verifyAUDITED
29 of 29
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity

Every figure was compared against the original statement: 0 failures and 0 presentation gaps.

What we don’t show

We’d rather say what’s missing than fill the gap with an estimate.

P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed